Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies
- 30 November 2009
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 220 (1), 133-142
- https://doi.org/10.1016/j.expneurol.2009.08.004
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- In vivo Evidence for Cerebral Depletion in High-Energy Phosphates in Progressive Supranuclear PalsyJournal of Cerebral Blood Flow & Metabolism, 2009
- Identification of a Novel Risk Locus for Progressive Supranuclear Palsy by a Pooled Genomewide Scan of 500,288 Single-Nucleotide PolymorphismsAmerican Journal of Human Genetics, 2007
- Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?Brain, 2007
- Pathological tau: a loss of normal function or a gain in toxicity?Nature Neuroscience, 2005
- Dysregulation of Gene Expression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia NigraJournal of Neuroscience, 2004
- Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy‐like tauopathyBrain, 2002
- Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhageJournal of Neurosurgery, 1992
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridineLife Sciences, 1985
- Parkinson's Disease in a Chemist Working with 1-Methyl-4-Phenyl-L,2,5,6-TetrahydropyridineThe New England Journal of Medicine, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983